-
RBC Likes Express Scripts After 'Sharp' Pullback
Wednesday, January 31, 2018 - 3:47pm | 457Read More...Health care stocks ended Tuesday's session mostly lower after three of America's most notable CEOs announced a collaboration to explore ways of improving employee health care services and slashing costs. At the same time, this created a unique buying opportunity for Express Scripts Holding...
-
Allscripts Has 20% Upside: Deutsche Bank Upgrades Stock To Buy
Monday, March 27, 2017 - 10:32am | 368Read More...Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) announced its targets for 2018–2020, with revenue growth guided to 6–8 percent and EPS growth of 12–15 percent. Both targets were ahead of the estimates but mostly in line with the consensus. Deutsche Bank’s George Hill...
-
Partisan Politics May Be To Blame For Hold Up In Walgreens-Rite Aid Deal
Wednesday, March 22, 2017 - 8:50am | 436Read More...Partisan politics may be holding up the impending M&A deal between Walgreens Boots Alliance Inc (NASDAQ: WBA) and Rite Aid Corporation (NYSE: RAD), Deutsche Bank said in a note earlier this week. Walgreens may try to force a Federal Trade Commission decision on the deal within 30 days, analysts...
-
Deutsche Bank Does Some DIY Math On CVS And The PBM Question
Wednesday, February 8, 2017 - 2:44pm | 385Read More...Deutsche Bank previewed the fourth-quarter results of CVS Health Corp (NYSE: CVS), while also doing some DIY math on DIR fees. The company is scheduled to release its results Thursday before the markets open. Q4 Expectations Analyst George Hill expects the company to report earnings per...
-
Analysts React To A Recut Walgreens-Rite Aid Deal
Tuesday, January 31, 2017 - 1:18pm | 401Read More...A revised merger deal from Walgreens Boots Alliance Inc (NASDAQ: WBA) and Rite Aid Corporation (NYSE: RAD) was largely due to regulatory concerns. When the amended agreement was announced, there was little change in the shares of Walgreens, but Rite Aid shares plunged to a new 52-week low on...
-
Divested Stores In Walgreens/Rite Aid Deal Will Go To Strategic Buyers, Not PE
Wednesday, November 9, 2016 - 2:31pm | 340Read More...Deutsche Bank believes that there is no threat to the completion of Walgreens Boots Alliance Inc (NASDAQ: WBA)'s acquisition of Rite Aid Corporation (NYSE: RAD). Minimal Headwinds To The Acquisition The firm pointed out checks have suggested private equity is not keen on buying divested stores, and...
-
Deutsche Bank Stops Short On Rite Aid: Downgrades To Hold
Friday, April 8, 2016 - 10:00am | 320Read More...Rite Aid Corporation (NYSE: RAD) reported its F4Q results largely in line with expectations, although the top line missed the estimate. Deutsche Bank’s George Hill downgraded the rating on the company from Buy to Hold, with a price target of $9. F4Q Results Rite Aid reported its EBITDA...
-
Express Scripts Moved To Sell At Deutsche Bank, Anthem Risk Too Much To Bear
Monday, February 22, 2016 - 8:40am | 290Read More...Deutsche Bank's George Hill has downgraded the rating on Express Scripts Holding Company (NASDAQ: ESRX) from Hold to Sell, while reducing the price target from $93 to $61. Hill believes that there could be downside risk of 11 percent to the stock, from the current levels. "Given the acrimony...
-
Deutsche Bank Boosts Quintiles, Equifax With Buy Ratings: Here's Why
Friday, February 12, 2016 - 11:22am | 476Read More...Shares of Quintiles Transnational Holdings Inc (NYSE: Q) and Equifax In.c (NYSE: EFX) have been trending lower in 2016 and are down 15 percent each. Deutsche Bank analysts have upgraded the ratings on both companies from Hold to Buy, while raising the price targets. Equifax is poised for...
-
Deutsche Bank Says MedAssets 'Wrestled Into Submission,' Downgrades To Hold
Wednesday, February 18, 2015 - 12:12pm | 169Read More...In a report published Tuesday, Deutsche Bank analyst George Hill commented that MedAssets, Inc. (NASDAQ: MDAS) pre-announced fourth quarter results of $0.39 was one penny short of what he expected and the company's 2015 guidance resulted in a negative view of shares. "Perhaps most unsettling is...
-
Deutsche Bank Analyst: Cerner's Contract Loss Won't Hurt
Tuesday, January 20, 2015 - 2:59pm | 203Read More...Cerner Corporation (NASDAQ: CERN) lost a major potential contract to its competitor Tuesday but an analyst said the company "should win its fair share" in the future. Deutsche Bank's George Hill said the deal is worth "hundreds of millions of dollars" and called it among...
-
Numerous Analysts Bullish On VWR Following Quiet Period Expiration
Tuesday, November 11, 2014 - 11:57am | 155Read More...On Tuesday , the analyst quiet period on shares of VWR Corp (NASDAQ: VWR) expired. Following the expiration, analysts at multiple firms initiated bullish coverage on the company. Goldman Sachs: Buy rating; $31 price target. Isaac Ro outlined three catalysts: Accelerating growth in...
-
UPDATE: Deutsche Bank Initiates Bullish Coverage On VWR
Tuesday, November 11, 2014 - 10:17am | 169Read More...On Tuesday, analysts at Deutsche Bank initiated coverage on VWR Corp (NASDAQ: VWR) with a Buy rating and $28 price target. George Hill feels the company offers upside for the following reasons. Attractive valuation with high degree of earnings and transparency: "VWR shares are currently...
-
Deutsche Bank Reiterates Coverage on McKesson on Attractive Risk-Reward Profile
Thursday, December 26, 2013 - 11:58am | 233Read More...In a report published Thursday, Deutsche Bank analyst George Hill maintained a Buy rating on McKesson Corporation (NYSE: MCK), with a $181.00 price target, despite Elliot’s decision to not tender shares. According to the report, “Elliott stated that its decision is binding, and the fund owns...
-
UPDATE: Deutsche Bank Initiates Coverage on Walgreens as the Path Feels Clear
Thursday, November 21, 2013 - 10:45am | 116Read More...In a report published Thursday, Deutsche Bank analyst George Hill initiated coverage on Walgreen Company (NYSE: WAG) with a Buy rating and $73.00 price target. In the report, Deutsche Bank noted, “We are initiating coverage of WAG shares with a Buy Rating and $73 price target. Walgreens is in the...
